Optiscan is excited to be featured in Sydney Morning Herald, The Age, Brisbane Times and Bulls N’ Bears following the launch of InForm™, our next-generation imaging device designed to revolutionize pathology with real-time, high-resolution digital imaging.

The article highlights how InForm™ expands Optiscan’s product portfolio in laboratory medicine and point-of-care settings, marking a significant step forward in the company’s strategic growth.

Built on Optiscan’s patented technology, InForm™ eliminates traditional diagnostic bottlenecks by providing instant, high-quality digital pathology images without the need for slide preparation. Its cloud-based telepathology platform and hospital system integration enable rapid triaging, faster sample assessments, and enhanced decision-making.

"Established pathology processes, which play a critical part in up to 70 per cent of all clinical decisions, often rely on labour-intensive slide preparation and lengthy interpretation leading to bottlenecks in diagnosis. Optiscan’s InForm offering, on the other hand, removes these hurdles by offering real-time imaging, high-resolution digital microscopy and cloud integration, significantly reducing the turnaround times and costs associated with current methods."

Speaking on the significance of this breakthrough, Optiscan CEO Dr. Camile Farah highlighted how InForm™ is shaping the future of digital pathology.

"The reveal of our revolutionary InForm device represents a significant advancement in the evolution of digital pathology. From bedside to laboratory and beyond, it enhances the speed, accuracy and flexibility of diagnostics," Dr. Farah said.

Read the Sydney Morning Herald full article here.

Read The Age full article here.

Read the Brisbane Times full article here.

Read the Bulls N’ Bears full article here.